Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$521K Sell
653
-347
-35% -$231K ﹤0.01% 678
2026
Q1
$545K Sell
1,000
-463
-32% -$189K ﹤0.01% 678
2025
Q4
$458K Sell
1,463
-563
-28% -$179K ﹤0.01% 824
2025
Q3
$547K Sell
2,026
-283
-12% -$64.8K ﹤0.01% 699
2025
Q2
$509K Sell
2,309
-2,853
-55% -$514K ﹤0.01% 726
2025
Q1
$677K Buy
5,162
+1,021
+25% +$142K ﹤0.01% 644
2024
Q4
$567K Sell
4,141
-3,186
-43% -$438K ﹤0.01% 761
2024
Q3
$743K Sell
7,327
-1,460
-17% -$115K ﹤0.01% 643
2024
Q2
$643K Sell
8,787
-4,140
-32% -$271K ﹤0.01% 714
2024
Q1
$653K Sell
12,927
-430
-3% -$20.2K ﹤0.01% 770
2023
Q4
$625K Buy
+13,357
New +$609K ﹤0.01% 826
2022
Q2
Sell
-36,975
Closed -$1.5M 1048
2022
Q1
$1.5M Buy
+36,975
New +$1.45M 0.01% 914
2021
Q4
Sell
-35,907
Closed -$1.57M 1023
2021
Q3
$1.57M Buy
+35,907
New +$1.62M 0.01% 874

Other funds holding AGX

Aviva's AGX Position: Q2 2026 in Review

Aviva reduced its Argan (AGX) stake by 35% in Q2 2026, selling an estimated $231K and leaving 653 shares worth $521K. The position accounts for ﹤0.01% of the portfolio, ranked #678.

Aviva first reported a position in AGX in Q3 2021 and has held it in 13 quarters since. The position peaked at $1.57M in Q3 2021. 562 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

  • Aviva held 653 shares of Argan worth $521K as of Q2 2026.
  • Aviva sold 347 Argan shares in Q2 2026, an estimated $231K.
  • Argan made up ﹤0.01% of Aviva's portfolio in Q2 2026, its #678 holding.
  • Aviva first reported a position in Argan in Q3 2021 and has held it in 13 quarters since.
  • Aviva's Argan position peaked at $1.57M in Q3 2021.
  • 562 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.